Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,043.27 +3.27 (+0.31%)
Streaming Delayed Price Updated: 1:03 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
The biotechnology sector has always been a high-stakes arena where clinical success can create multi-billion-dollar empires overnight, and a failed negotiation can erase a fifth of a company’s market... 
Via Finterra
Topics Economy Initial Public Offering
News headline image
Prediction: This Healthcare Stock Could Soar by 40% in 2026 ↗
This pharmaceutical giant has recently caught fire, and the stock's run is likely just beginning. 
Via The Motley Fool
News headline image
My Top AI Healthcare Stock to Buy and Hold for 20 Years ↗
This drugmaker continues to strengthen its investment thesis. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
Eli Lilly & Co (NYSE:LLY) Presents a Compelling Mix of Fundamental Growth and Technical Breakout Potential ↗
Via Chartmill
Novo Nordisk In Green After Oral Wegovy Clocks Over 18K Prescriptions In A Week ↗
Via Stocktwits
ELI LILLY & CO (NYSE:LLY) Offers a Durable Dividend with Strong Growth and Financial Health ↗
Via Chartmill
News headline image
3 Mid-Cap Stocks with Open Questions
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
News headline image
3 Growth Stocks to Invest $1,000 in Right Now ↗
It comes as no surprise that all three of them are capitalizing on relatively new, but game-changing, developments. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Should You Dump Eli Lilly's Shares After This Setback? ↗
The company got some bad news to start 2026. 
Via The Motley Fool
News headline image
Google, Nvidia, Lilly Lead 5 Stocks Near Buy Points ↗
These trillion-dollar stocks may be setting up for their next move. 
Via Investor's Business Daily
News headline image
The $5 Trillion Renaissance: How 2025 Redefined Global Deal-Making
The global financial landscape has undergone a seismic shift as 2025 closed with merger and acquisition (M&A) volumes surpassing a staggering $5 trillion. This "M&A Renaissance" marks a definitive end... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? ↗
Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing. 
Via The Motley Fool
News headline image
Why a 15% Dividend Wasn’t Enough to Keep This $3.3 Million Position ↗
Trinity Capital provides venture debt and equipment financing to growth-stage tech companies seeking non-dilutive capital solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Outfront Media Surges 40% in One Year, Then Gets Cut Loose Despite 'Exceptional Performance' ↗
This out-of-home advertising REIT connects brands with urban audiences through a broad network of billboard and transit assets. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
Date: January 23, 2026 Introduction In the high-stakes arena of metabolic medicine, few companies have generated as much speculative fervor and clinical awe as Viking Therapeutics (NASDAQ: VKTX). As of... 
Via Finterra
Topics Intellectual Property
News headline image
Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock? ↗
Novo Nordisk stock rose Friday on report its oral Wegovy clocked 18,000 prescriptions in its second week on the market. 
Via Investor's Business Daily
News headline image
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗
This biotech has candidates in late-stage clinical development. 
Via The Motley Fool
News headline image
2 Mega-Cap Stocks to Target This Week and 1 We Find Risky
Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing... 
Via StockStory
News headline image
The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
Eli Lilly (NYSE: LLY) has once again demonstrated its resilience and market-leading strength, logging a significant 5.2% gain over the last five trading days as of January 22, 2026. This recent rally... 
Via MarketMinute
Topics Economy
News headline image
The Great Broadening: Why Early 2026 is Redefining the Market’s Winning Ticket
As the first month of 2026 draws to a close, the narrative that dominated Wall Street for the better part of three years—the undisputed reign of mega-cap technology—is rapidly fracturing. In its place,... 
Via MarketMinute
Topics Economy
News headline image
As Jensen Huang Preps to Visit China, How Should You Play Nvidia Stock?
Nvidia is a tech stock that has outpaced the broader markets by a significant margin over the past decade. Is NVDA still a good buy as Jensen Huang prepares to visit China? 
Via Barchart.com
Topics Artificial Intelligence Government Supply Chain
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year... 
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
Eli Lilly (LLY) Q2 2025 Earnings Call Transcript ↗
Eli Lilly (LLY) Q2 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript ↗
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript ↗
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly and Co&#39;s Options Frenzy: What You Need to Know ↗
 
Via Benzinga
News headline image
ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
Why Eli Lilly (LLY) Stock Is Up Today
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation for its... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine
In a move that signals the arrival of the "Bio-Computing" era, NVIDIA (NASDAQ: NVDA) and Eli Lilly (NYSE: LLY) have officially launched a landmark $1 billion AI co-innovation lab. Announced during the... 
Via TokenRing AI
Topics Artificial Intelligence Economy Intellectual Property
News headline image
J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape
NEW BRUNSWICK, N.J. — In a landmark display of resilience and strategic pivoting, Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2025 revenues of $24.56 billion on Wednesday, January 21, 2026,... 
Via MarketMinute
Topics Earnings Economy Government
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.